AI curing cancer has become a meme. This Google researcher is actually trying to do it.

Google Research head Yossi Matias discusses Co-Scientist and ERA, two AI systems designed to accelerate scientific discovery by generating hypotheses and automating model building. Early results published in Nature include drug-repurposing leads for acute myeloid leukemia and insights on antimicrobial resistance. Matias also cited an NHS breast-cancer study where AI caught 25% of missed cases and reclaimed 40% of doctors’ time. The interview frames these advances as long-term enablers of healthcare and research productivity, implying potential commercial and strategic upside for Google as AI capabilities are integrated into healthcare, life-sciences partnerships, and enterprise research tools. For investors, successful translation of these technologies into products or partnerships could strengthen Google’s growth narrative in AI applications beyond search and advertising.